Autopsy report · NCT00698503

A Clinical Investigation of the M2a- 38™ Hip System

“due to low follow up”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 years 5 months after it had already started.
• Ran for about 6 years 11 months before it stopped.
• 190 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Biomet Orthopedics, LLC

Sponsor type

Industry

Conditions

Non-inflammatory Degenerative Joint Disease; Osteoarthritis; Avascular Necrosis

Participants

190

Trials that died the same way

• Slotted Hole Versus Fixed Hole C-Tek
  “Due to lack of follow-up information” (69% match in meaning)
• Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
  “due to poor response” (59% match in meaning)
• Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in Children
  “Loss of participants to follow-up” (58% match in meaning)
• Pioglitazone for Oral Premalignant Lesions
  “Due to slow accrual.” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.